232
Participants
Start Date
May 1, 2024
Primary Completion Date
September 1, 2024
Study Completion Date
May 1, 2026
Description of clinical, immunological and tumor features of patients harboring CV2 Abs
This is a non-interventional study involving clinical data and biological samples (DNA and tumors block). Demographic and clinical data already collected in the database of the French Reference Center on PNS will be reviewed. The diagnostic tests performed to detect CV2-Abs in the patients already included in the database of the French Reference Center on PNS will be retrospectively analyzed.
Hôpital Neurologique Pierre Wertheimer / Groupement Hospitalier Est, Bron
Hospices Civils de Lyon
OTHER